What Is Peptide Therapy? Complete Guide for 2026

Peptide therapy is one of the fastest-growing areas in functional and longevity medicine, yet it remains poorly understood by most patients — and even by many clinicians trained outside this specialty. The term "peptide therapy" encompasses dozens of different compounds with vastly different mechanisms and applications, from accelerating tissue healing to stimulating growth hormone release to supporting cognitive performance. What unites them is a common molecular structure and a shared principle: using the body's own signaling language to influence its function.

This guide provides a comprehensive, medically grounded overview of peptide therapy — what peptides are, how they work biologically, the major therapeutic categories, the most widely used specific peptides, and how to determine whether you might be a candidate for a peptide program.

What Are Peptides?

Peptides are short chains of amino acids — the same building blocks that make up proteins. The distinction between a peptide and a protein is primarily one of length: peptides typically contain between 2 and 50 amino acids, while proteins are longer chains that fold into complex three-dimensional structures.

The human body naturally produces thousands of peptides that serve as signaling molecules — hormones, neurotransmitters, growth factors, and immune modulators. Insulin, for example, is a peptide hormone. So are oxytocin, glucagon, and many of the growth factors that regulate tissue repair and immune function. Peptides communicate between cells, organs, and systems by binding to specific receptors and initiating cascading biological responses.

Therapeutic peptides are either identical to naturally occurring human peptides, structurally modified analogs designed to have enhanced stability or activity, or novel sequences developed to trigger specific receptor pathways. Most therapeutic peptides are administered by subcutaneous injection because peptides are broken down in the digestive tract when taken orally, though some formulations — particularly intranasal and topical preparations — are increasingly available.

How Peptide Therapy Works

The therapeutic logic of peptide therapy is fundamentally different from that of pharmaceutical drugs designed to block or suppress biological processes (like statins, antihypertensives, or NSAIDs). Peptides, broadly speaking, work by amplifying, restoring, or redirecting biological signals that the body already uses.

As we age, the endogenous production of many critical peptides declines. Growth hormone secretion drops dramatically after the third decade of life. Tissue-repair peptides become less abundant. Immune regulatory signals become dysregulated. Peptide therapy in the clinical context is often about restoring youthful signaling patterns rather than introducing entirely foreign pharmacological agents.

This has important implications for safety: because many therapeutic peptides are structurally similar or identical to naturally occurring molecules, the side effect profiles tend to be more favorable than traditional pharmaceutical agents — though this does not mean they are without risk or that they should be used without medical supervision.

Major Categories of Therapeutic Peptides

1. Growth Hormone Secretagogues (GHS)

These are perhaps the most widely used category of peptides in clinical practice. Rather than directly administering human growth hormone (HGH) — which is tightly regulated, expensive, and carries risks including suppression of the body's natural GH production — GH secretagogues work by stimulating the pituitary gland to produce and release more of its own growth hormone.

This approach preserves the normal pulsatile rhythm of GH release, which is important for maintaining physiological signaling patterns. GH secretagogues are used for goals including improved body composition (increased lean muscle, reduced body fat), enhanced recovery, improved sleep quality, increased bone density, and anti-aging applications.

2. Healing and Repair Peptides

This category includes peptides that accelerate tissue healing, reduce inflammation, and support recovery from injury or surgery. They are used by athletes recovering from sports injuries, by patients with chronic inflammatory conditions, and increasingly in post-surgical recovery protocols.

3. Cognitive and Neuroprotective Peptides

Peptides in this class influence neurotransmitter systems, promote neuroplasticity, and may protect against neurodegenerative processes. They are being explored for applications ranging from improving focus and memory to supporting recovery from traumatic brain injury.

4. Metabolic and Weight Management Peptides

GLP-1 receptor agonists (semaglutide, tirzepatide) are technically peptide drugs and represent the most commercially successful peptide medications in history. Beyond these, other peptides influence insulin sensitivity, fat oxidation, and appetite regulation.

Key Peptides: What They Are and What They Do

Sermorelin

Sermorelin is a synthetic analog of growth hormone-releasing hormone (GHRH), the hypothalamic signal that tells the pituitary to release GH. It is one of the most widely prescribed GH secretagogues in clinical practice and has the longest track record of use.

Sermorelin stimulates a natural, pulsatile release of growth hormone, preserving the body's feedback regulation. Clinical applications include addressing age-related GH decline, improving body composition, enhancing sleep quality (much GH is released during slow-wave sleep), and supporting recovery.

It is typically administered via subcutaneous injection, most commonly at bedtime to coincide with the natural nocturnal GH pulse. Because it works through the body's own pituitary axis, it tends to have a favorable safety profile and does not fully suppress endogenous GH production.

CJC-1295

CJC-1295 is a modified GHRH analog engineered to have a much longer half-life than native GHRH or sermorelin. Where sermorelin has a half-life of minutes, CJC-1295 (particularly in the DAC [Drug Affinity Complex] formulation) can remain active for days to weeks by binding to plasma albumin.

This longer duration allows less frequent dosing while maintaining continuous stimulation of GH release. CJC-1295 is most commonly used in combination with a GHRP (growth hormone-releasing peptide) such as Ipamorelin, as the two mechanisms act synergistically to produce significantly greater GH release than either alone.

Ipamorelin

Ipamorelin is a growth hormone-releasing peptide (GHRP) that stimulates GH release through a different receptor pathway than GHRH analogs — specifically, the ghrelin receptor (also called the GHS-R). What distinguishes Ipamorelin from earlier GHRPs (like GHRP-2 and GHRP-6) is its selectivity: it stimulates GH release with minimal effect on cortisol or prolactin, hormones that older GHRPs often elevated as an unwanted side effect.

The CJC-1295 / Ipamorelin combination is one of the most commonly prescribed peptide stacks in clinical practice. Used together, they stimulate a robust, physiologically appropriate GH pulse with a favorable safety profile.

BPC-157 (Body Protection Compound-157)

BPC-157 is a pentadecapeptide (15 amino acids) derived from a protein found in human gastric juice. It has been extensively studied in animal models for its striking tissue-healing and anti-inflammatory properties. Research has shown it accelerates healing in tendons, ligaments, muscles, and the gastrointestinal tract; reduces inflammation; promotes angiogenesis (formation of new blood vessels in healing tissue); and exhibits neuroprotective effects in models of brain injury.

Human clinical trial data on BPC-157 remains limited compared to its extensive preclinical literature, and it is not FDA-approved for any indication. However, it is widely used in compounding-based clinical practice for musculoskeletal injuries, chronic inflammatory conditions, gut health issues, and recovery support. It can be administered via injection (for systemic effects) or orally (for gastrointestinal applications, as the GI tract is its natural source).

TB-500 (Thymosin Beta-4)

Thymosin beta-4 is a naturally occurring, highly conserved peptide found in virtually all human cells. It plays a central role in cell motility, wound healing, tissue repair, and inflammation modulation. TB-500 is a synthetic fragment of thymosin beta-4 that retains much of its biological activity.

TB-500 has demonstrated anti-inflammatory properties, promotion of angiogenesis, and acceleration of repair in muscle, tendon, cardiac, and neural tissues in preclinical models. Like BPC-157, it lacks extensive human clinical trial data and is not FDA-approved as a standalone drug. It is used clinically for recovery from injuries and surgery, and is sometimes combined with BPC-157 as a tissue-repair "stack."

Peptide Therapy Category Overview

Peptide	Category	Primary Mechanism	Common Applications
Sermorelin	GH Secretagogue	GHRH receptor agonist	Body composition, sleep, recovery, anti-aging
CJC-1295	GH Secretagogue	Long-acting GHRH analog	GH optimization, lean mass, fat loss
Ipamorelin	GH Secretagogue	Selective GHRP (ghrelin receptor)	GH pulse amplification, sleep quality
BPC-157	Healing / Repair	Angiogenesis, anti-inflammatory	Tendon/ligament healing, gut health, recovery
TB-500	Healing / Repair	Thymosin beta-4 activity	Tissue repair, inflammation, cardiac healing

Who Is a Candidate for Peptide Therapy?

Peptide therapy is not a monolithic intervention — it means different things for different patients. Appropriate candidates depend heavily on which peptides are being considered and for what purpose:

GH Secretagogue Candidates

• Adults over 35 experiencing age-related decline in muscle mass, increased body fat, reduced recovery, or poor sleep quality that may be related to declining GH output
• Athletes or highly active individuals seeking to optimize recovery and body composition
• Patients with documented low IGF-1 levels (a surrogate marker for GH status) without a specific medical diagnosis requiring recombinant HGH

GH secretagogues are generally not appropriate for patients with active cancer or a history of certain cancers (as GH signaling can potentially promote tumor growth), patients with untreated hypothyroidism, or patients with pituitary disease. A thorough medical evaluation and appropriate lab work are essential before starting.

Healing Peptide Candidates

• Athletes with recurring tendon, ligament, or joint injuries who want to accelerate rehabilitation
• Patients recovering from orthopedic surgery
• Individuals with chronic inflammatory musculoskeletal conditions
• Patients with inflammatory bowel issues who may benefit from BPC-157's GI-protective properties

What to Expect When Starting Peptide Therapy

Peptide therapy is not an overnight intervention. Results accumulate over weeks to months as signaling patterns shift and downstream effects compound. For GH secretagogues, improvements in sleep quality are often the first noticeable benefit — typically within the first 2–4 weeks. Body composition changes tend to be more gradual, occurring over 3–6 months of consistent use. For healing peptides, the timeline depends on the severity and nature of the injury being addressed.

Most peptide protocols are cyclical — patients use the peptides for a defined period (often 3–6 months), take a break, and then resume if appropriate. This cycling approach helps prevent receptor desensitization and maintains the body's natural production pathways.

Side effects of peptide therapy, when it occurs, are typically mild. GH secretagogues can occasionally cause water retention, tingling in the extremities, or temporary increases in fasting blood glucose — effects that are dose-dependent and usually resolve with dose adjustment. Injection site reactions are possible with any subcutaneously administered peptide.

Peptide Therapy at Truventa Medical

Truventa Medical offers personalized peptide therapy programs designed by licensed physicians and available in all 50 states via telehealth. Our clinical team evaluates your health history, goals, and relevant lab work to design a protocol appropriate for your specific needs — whether that's GH optimization, tissue healing support, or metabolic improvement.

Peptides prescribed through Truventa are sourced from licensed compounding pharmacies and shipped directly to your home. Our providers offer ongoing monitoring to track your progress and adjust your protocol as needed. No in-person visit is required to get started. Results may vary based on individual factors including age, baseline hormone levels, lifestyle, and adherence.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Results may vary. Consult your doctor before starting any new treatment.